H1B Salary Data

Home › Employers › Upsite Clinical, Inc.

Upsite Clinical, Inc.: H-1B salaries and sponsorship

Upsite Clinical, Inc. filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $82,500.

Applications (LCAs)4
Certified4
Employer addressTiburon, CA
H-1B dependent employerNo
Median offered salary$82,500
Middle half of salaries$77,500–$91,409
10th–90th percentile$73,000–$102,944

Does Upsite Clinical, Inc. sponsor H-1B visas?

Upsite Clinical, Inc. filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on May 15, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Associate, Software Engineer2$97,818
Associate Data Scientist1$70,000
Associate AI Engineer1$80,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20254$82,500

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Associate, Software Engineer$110,635
Level I
Seattle, WAMay 15, 2025Oct 1, 2025Certified
Associate Data Scientist$70,000
Level I
Tustin, CADec 9, 2024Jan 1, 2025Certified
Associate, Software Engineer$85,000
Level I
Quincy, MADec 5, 2024Jan 1, 2025Certified
Associate AI Engineer$80,000
Level I
Wellesley, MADec 5, 2024Jan 1, 2025Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).